Fluditek, syrup 5% 125 ml

The mucolytic and expectorant effect of Fluditek is due to the activation of sialic transferase – an enzyme of the bocalytic cells of the bronchial mucosa. It normalizes the quantitative ratio of acidic and neutral sialomucin of bronchial secretion, restores viscosity and elasticity of mucus.

Promotes regeneration of the mucous membrane, normalizes its structure, activates the ciliated epithelium. Restores the secretion of immunologically active IgA (specific protection) and the number of sulfhydryl groups of mucus components (nonspecific protection), improves mucociliary clearance.

Restores the secretion of immunologically active IgA (specific protection) and the number of sulfhydryl groups of mucus components (non-specific protection).

Pharmacokinetics

After oral administration Cmax in blood serum and in respiratory mucosa is reached after 2-3 hours and persists in mucosa for 8 hours. It is excreted mainly by the kidneys, partially – unchanged, partially – as metabolites.

Indications

Bronchitis, Runny nose (rhinitis), Cough, Sinusitis, Cold

• Acute and chronic bronchopulmonary diseases accompanied by formation of viscous, difficult to separate sputum (tracheitis, bronchitis, tracheobronchitis, bronchial asthma, bronchiectatic disease).
• Acute and chronic inflammatory diseases of the middle ear, nose and its accessory sinuses, accompanied by formation of viscous, hardly detachable mucus (rhinitis, otitis media, sinusitis).
  

Active ingredient

Carbocysteine

Composition

100 ml of syrup contains:

the active ingredient:

carbocysteine 5 g

excipients:

sugarose,

caramel flavoring,

glycerin,

sodium hydroxide,

/p>

yellow-orange dye S,

purified water,

proprietary blue dye

conservative:

methyl parahydroxybenzoate

How to take, the dosage

Adults are prescribed 750 mg (15 ml of syrup for adults) 3 times a day.

Please note that 15 ml are contained in 1 tablespoon.

Interaction

When used concomitantly Fluditek increases the effectiveness of glucocorticosteroid (mutual) and antibacterial therapy of inflammatory diseases of the upper and lower respiratory tract.

When used concomitantly, Fluditek increases the bronchodilator effect of theophylline.

The activity of carbocysteine is weakened by anti-cough and atropine-like agents.

Special Instructions

Patients with diabetes or on a low-carbohydrate diet should note that 1 tablespoon of 5% syrup contains 5.25 grams of sucrose. The presence of sucrose may be a cause of flatulence and dyspepsia in young children.

In a salt-free or low-salt diet, the sodium content of the drug should be considered.

Fluditek in syrup form 5% is for adults and children over 15 years of age only.

Contraindications

• hypersensitivity to carbocysteine or other components of Fluditek;
• Gastric and duodenal ulcer (acute stage);
• chronic glomerulonephritis (acute stage), cystitis;
• children under 15 years of age;
• pregnancy (1st trimester).

With caution: chronic glomerulonephritis (in anamnesis); peptic ulcer (in anamnesis); pregnancy (II-III trimester); breast-feeding.

.

Side effects

Nausea, vomiting, diarrhea, epigastric pain, flatulence, gastrointestinal bleeding, dizziness, weakness, malaise, in single cases – allergic reactions (itching, urticaria, exanthema, angioedema).

If any of the side effects mentioned in the description worsen, or if the patient notices any other side effects not mentioned in the description, the patient should tell the physician.

Overdose

Symptoms: gastralgia, nausea, diarrhea.

Treatment: symptomatic therapy.

.

Pregnancy use

The use of the drug Fluditek in the first trimester of pregnancy is contraindicated.

With caution should be prescribed Fluditec in the second and third trimesters of pregnancy and during breast-feeding.

Preventive use in children

Contraindication: childhood age 15 years.

.

Similarities

Fluifort, Bronchobos, Libexin Muco